Icosavax Stock Shares Outstanding
Icosavax fundamentals help investors to digest information that contributes to Icosavax's financial success or failures. It also enables traders to predict the movement of Icosavax Stock. The fundamental analysis module provides a way to measure Icosavax's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Icosavax stock.
Icosavax |
Icosavax Company Shares Outstanding Analysis
Icosavax's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Icosavax Shares Outstanding | 50.23 M |
Most of Icosavax's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Icosavax is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Icosavax has 50.23 M of shares currently outstending. This is 72.18% lower than that of the Biotechnology sector and 52.99% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 91.22% higher than that of the company.
Icosavax Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Icosavax's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Icosavax could also be used in its relative valuation, which is a method of valuing Icosavax by comparing valuation metrics of similar companies.Icosavax is currently under evaluation in shares outstanding category among its peers.
Icosavax Fundamentals
Return On Equity | -0.42 | |||
Return On Asset | -0.27 | |||
Current Valuation | 547.9 M | |||
Shares Outstanding | 50.23 M | |||
Shares Owned By Insiders | 3.47 % | |||
Shares Owned By Institutions | 87.64 % | |||
Number Of Shares Shorted | 321.31 K | |||
Price To Earning | 63.56 X | |||
Price To Book | 3.31 X | |||
Price To Sales | 153.31 X | |||
Gross Profit | (30.97 M) | |||
EBITDA | (103.19 M) | |||
Net Income | (96.71 M) | |||
Cash And Equivalents | 242.8 M | |||
Cash Per Share | 6.09 X | |||
Total Debt | 8.79 M | |||
Debt To Equity | 0.03 % | |||
Current Ratio | 20.89 X | |||
Book Value Per Share | 4.64 X | |||
Cash Flow From Operations | (71.48 M) | |||
Short Ratio | 0.34 X | |||
Earnings Per Share | (2.20) X | |||
Target Price | 18.5 | |||
Number Of Employees | 60 | |||
Beta | 1.28 | |||
Market Capitalization | 769.04 M | |||
Total Asset | 238.68 M | |||
Retained Earnings | (185.83 M) | |||
Working Capital | 210.12 M | |||
Z Score | 51.0 | |||
Net Asset | 238.68 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.ZLAB | Zai Lab | |
ASLE | AerSale Corp | |
ATS | AT S Austria |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Icosavax Stock
If you are still planning to invest in Icosavax check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Icosavax's history and understand the potential risks before investing.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |